Citations

Citations to this article as recorded by  

• Radiomics Integration of Mammography and DCE-MRI for Predicting Molecular Subtypes in Breast Cancer Patients
  Xianwei Yang, Jing Li, Hang Sun, Jing Chen, Jin Xie, Yonghui Peng, Tao Shang, Tongyong Pan
  Breast Cancer: Targets and Therapy.2025; Volume 17: 187.     CrossRef
• HER2 (2+)/SISH-positive vs. HER2 (3+) Breast Cancer: Pre-treatment MRI Differences and Accuracy of pCR Prediction on Post-treatment MRI
  Ga Eun Park, Han Song Mun, Sung Hun Kim, Bong Joo Kang
  Academic Radiology.2025;[Epub]     CrossRef
• Association of clinicopathologic and molecular factors with the occurrence of positive margins in breast cancer
  Anupama Praveen Kumar, Diego Vicente, Jianfang Liu, Praveen-Kumar Raj-Kumar, Brenda Deyarmin, Xiaoying Lin, Craig D. Shriver, Hai Hu
  Breast Cancer Research and Treatment.2024; 204(1): 15.     CrossRef
• The association of magnetic resonance imaging features with five molecular subtypes of breast cancer
  Van Thi Nguyen, Duc Huu Duong, Quang Thai Nguyen, Duy Thai Nguyen, Thi Linh Tran, Tra Giang Duong
  European Journal of Radiology Open.2024; 13: 100585.     CrossRef
• The effect of data resampling methods in radiomics
  Aydin Demircioğlu
  Scientific Reports.2024;[Epub]     CrossRef
• Treated Primary Cutaneous Malignant Melanoma With Later Metastasis Found in Clinical Presentation of Left Axilla Lymphadenopathy: A Case Report
  Brigitte L Cochran, Sara Eliseo, Austin Vaughn, Tamryn L Van Der Horn, Enzo Ferrara, Jamie Edwards
  Cureus.2024;[Epub]     CrossRef
• Pushing the envelope in breast conserving surgery − is multiple-wire localization (3 or more wires) associated with increased risk of compromised margins and long-term recurrence?
  Orit Golan, Marian Khatib, Tehillah S. Menes, Vivianne A.R. Freitas, Rivka Kessner, Rina Neeman, Michal Mauda-Havakuk, Diego Mercer, Yoav Amitai
  European Journal of Radiology.2024; 176: 111511.     CrossRef
• A model combining BI-RADS® descriptors from pre-treatment B-mode breast ultrasound with clinicopathological tumor features shows promise in the prediction of residual disease after neoadjuvant chemotherapy
  Panagiotis Kapetas, Reena Aggarwal, Basmah Altuwayjiri, Katja Pinker, Paola Clauser, Thomas H. Helbich, Pascal A.T. Baltzer
  European Journal of Radiology.2024; 178: 111649.     CrossRef
• Correlations of Imaging and Therapy in Breast Cancer Based on Molecular Patterns: An Important Issue in the Diagnosis of Breast Cancer
  Oana Maria Burciu, Ioan Sas, Tudor-Alexandru Popoiu, Adrian-Grigore Merce, Lavinia Moleriu, Ionut Marcel Cobec
  International Journal of Molecular Sciences.2024; 25(15): 8506.     CrossRef
• Access to prior screening mammograms affects the specificity but not sensitivity of radiologists' performance
  J.D. Akwo, P. D. (Yun) Trieu, M.L. Barron, T. Reynolds, S.J. Lewis
  Clinical Radiology.2024; 79(12): e1549.     CrossRef
• Machine learning-based radiomics prognostic model for patients with proximal esophageal cancer after definitive chemoradiotherapy
  Linrui Li, Zhihui Qin, Juan Bo, Jiaru Hu, Yu Zhang, Liting Qian, Jiangning Dong
  Insights into Imaging.2024;[Epub]     CrossRef
• LYMPH NODES MORPHOLOGICAL CHANGES AND BREAST CANCER SUBTYPES IN PREDICTION OF METASTASES
  J. N. Akhundova, M. F. Amirova
  World of Medicine and Biology.2024; 20(90): 15.     CrossRef
• Axillary lymph node changes in different molecular subtypes of breast cancer
  J.N. Akhundova
  Український радіологічний та онкологічний журнал.2024; 32(4): 529.     CrossRef
• Histogram analysis of multi-model high-resolution diffusion-weighted MRI in breast cancer: correlations with molecular prognostic factors and subtypes
  Yanjin Qin, Feng Wu, Qilan Hu, Litong He, Min Huo, Caili Tang, Jingru Yi, Huiting Zhang, Ting Yin, Tao Ai
  Frontiers in Oncology.2023;[Epub]     CrossRef
• ASO Author Reflections: Sequence of Treatment in Clinically Node-Negative T1 Triple-Negative Breast Cancer
  Kai Huang, James W. Jakub, Sarah A. McLaughlin
  Annals of Surgical Oncology.2023; 30(13): 8455.     CrossRef
• Circulating non-coding RNAs as a diagnostic and management biomarker for breast cancer: current insights
  Hamed Hosseinalizadeh, Mehrdad Mahmoodpour, Ammar Ebrahimi
  Molecular Biology Reports.2022; 49(1): 705.     CrossRef
• MRI as a biomarker for breast cancer diagnosis and prognosis
  Francesca Galati, Veronica Rizzo, Rubina Manuela Trimboli, Endi Kripa, Roberto Maroncelli, Federica Pediconi
  BJR|Open.2022;[Epub]     CrossRef
• Multiparametric MRI Features of Breast Cancer Molecular Subtypes
  Madalina Szep, Roxana Pintican, Bianca Boca, Andra Perja, Magdalena Duma, Diana Feier, Bogdan Fetica, Dan Eniu, Sorin Marian Dudea, Angelica Chiorean
  Medicina.2022; 58(12): 1716.     CrossRef
• Circulating tumor cells as prognostic biomarkers in breast cancer: current status and future prospects
  Evagelia Chantzara, Nikolaos Xenidis, Galatea Kallergi, Vassilis Georgoulias, Athanasios Kotsakis
  Expert Review of Molecular Diagnostics.2021; 21(10): 1037.     CrossRef